BHC Insider Trading Activity and SEC Form 4 Filings
BHC insider trading summary
Over the past 12 months, insiders at Bausch Health Companies Inc. (BHC) reported 5 sales worth $507K by 3 insiders and 1 open-market purchase worth $15.6M by 1 insider on SEC Form 4. Net insider buying was $15.1M.
Latest BHC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Aimee J. Lenar | President, US Pharma | Sell | $259K (36,827 @ $7.03) |
| May 19, 2026 | Frank D. Lee | Director | Sell | $133K (24,456 @ $5.43) |
| Mar 3, 2026 | Seana Carson | EVP, General Counsel | Sell | $26K (4,420 @ $5.77) |
| Mar 2, 2026 | Seana Carson | EVP, General Counsel | Sell | $40K (6,856 @ $5.78) |
| Feb 27, 2026 | Seana Carson | EVP, General Counsel | Sell | $50K (8,388 @ $5.95) |
| Nov 25, 2025 | Paulson & Co. Inc. | Insider | Buy | $15.6M (2,500,000 @ $6.25) |
| Sep 8, 2025 | Seana Carson | EVP, General Counsel | Sell | $98K (13,370 @ $7.31) |
| Aug 21, 2025 | Frank D. Lee | Director | Sell | $122K (15,912 @ $7.66) |
| Aug 14, 2025 | John Paulson | Insider | Buy | $312.5M (34,721,118 @ $9.00) |
| Aug 13, 2025 | John Paulson | Insider | Buy | $610K (86,409 @ $7.06) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.